ArticleMedicine2022

Timing of tofacitinib therapy is critical to improving outcomes in severe-critical COVID-19 infection: A retrospective study from a tertiary care hospital.

Ramya Kodali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.